(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-1.01%) $83.00
(-1.16%) $1.619
(-0.44%) $2 336.90
(-0.84%) $27.31
(0.43%) $926.10
(-0.16%) $0.933
(-0.12%) $11.01
(-0.19%) $0.799
(0.00%) $92.17
-0.39% INR 1 239.90
Live Chart Being Loaded With Signals
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents...
Stats | |
---|---|
Šios dienos apimtis | 14 114.00 |
Vidutinė apimtis | 31 910.00 |
Rinkos kapitalizacija | 29.00B |
EPS | INR3.43 ( 2023-11-02 ) |
Last Dividend | INR2.00 ( 2023-09-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 73.80 |
ATR14 | INR1.866 (0.15%) |
Tūris Koreliacija
Tatva Chintan Pharma Chem Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Tatva Chintan Pharma Chem Koreliacija - Valiuta/Žaliavos
Tatva Chintan Pharma Chem Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR4.24B |
Bruto pelnas: | INR1.98B (46.63 %) |
EPS: | INR20.52 |
FY | 2022 |
Pajamos: | INR4.24B |
Bruto pelnas: | INR1.98B (46.63 %) |
EPS: | INR20.52 |
FY | 2022 |
Pajamos: | INR4.31B |
Bruto pelnas: | INR2.24B (51.85 %) |
EPS: | INR44.59 |
FY | 2021 |
Pajamos: | INR2.97B |
Bruto pelnas: | INR1.41B (47.63 %) |
EPS: | INR26.02 |
Financial Reports:
No articles found.
Tatva Chintan Pharma Chem Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR2.00 | 2022-09-08 |
Last Dividend | INR2.00 | 2023-09-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR4.00 | -- |
Avg. Dividend % Per Year | 0.04% | -- |
Score | 1.37 | -- |
Div. Sustainability Score | 2.47 | |
Div.Growth Potential Score | 3.05 | |
Div. Directional Score | 2.76 | -- |
Year | Amount | Yield |
---|---|---|
2022 | INR2.00 | 0.08% |
2023 | INR2.00 | 0.09% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
APOLSINHOT.NS | Dividend Junior | 2023-09-22 | Annually | 10 | 0.11% | |
TDPOWERSYS.NS | Dividend Junior | 2023-08-02 | Annually | 13 | 0.31% | |
OLECTRA.NS | Dividend Junior | 2023-09-21 | Sporadic | 23 | 0.03% | |
INTENTECH.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.44% | |
COROMANDEL.NS | Dividend Knight | 2023-07-13 | Annually | 19 | 1.02% | |
SHALBY.NS | Dividend Junior | 2023-08-08 | Annually | 6 | 0.51% | |
MANALIPETC.NS | Dividend Junior | 2023-09-15 | Annually | 18 | 1.50% | |
GPPL.NS | Dividend Knight | 2023-07-26 | Semi-Annually | 9 | 2.89% | |
AXISBANK.NS | Dividend Junior | 2023-07-06 | Sporadic | 26 | 0.06% | |
TRU.NS | Dividend Junior | 2023-09-18 | Annually | 3 | 0.01% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0898 | 1.500 | 8.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0607 | 1.500 | -0.437 | -0.655 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.15 | 1.000 | 9.20 | 9.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 7.52 | [0 - 30] |
freeCashFlowPerShareTTM | 18.73 | 2.00 | 0.637 | 1.273 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.505 | 1.000 | 4.91 | 4.91 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.117 | 1.000 | 9.66 | 9.66 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.47 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 76.94 | 1.000 | 2.33 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0607 | 2.50 | -0.281 | -0.655 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 1.273 | [0 - 30] |
dividendYielPercentageTTM | 0.161 | 1.500 | 5.97 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 18.73 | 2.00 | 3.76 | 7.52 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.104 | 1.000 | 9.89 | 0 | [0.1 - 0.5] |
Total Score | 3.05 |
Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.